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Abstract.  Bovine adrenal chromaffin cells have nico- 
tinic acetylcholine receptors (AChRs) that mediate re- 
lease of catecholamines from the cells in response to 
synaptic input, and resemble neuronal AChRs in phar- 
macology and antigenic profile. Results presented here 
show that a  cAMP-dependent process enhances the 
function of adrenal chromaffin AChRs as a population 
in the plasma membrane.  This was demonstrated by 
showing that cAMP analogues cause specific increases 
both in the level of nicotine-induced catecholamine re- 
lease from the cells and in the level of the nicotine- 
induced conductance change occurring in the cells. 
Neither de novo synthesis of receptors nor transport of 
preexisting intracellular receptors to the plasma mem- 
brane is necessary for the enhancement. The respon- 
siveness of AChRs to regulation by the cAMP-depen- 
dent process appears to depend on the length of time 
the receptors have been on the cell surface. AChRs 
newly inserted into the plasma membrane generate a 
greater nicotinic response than do older AChRs and, 
unlike older AChRs, their response to agonist is not 
enhanced after treatment of the cells with cAMP ana- 
logues. The findings indicate that the AChRs and/or 
associated components undergo a  maturation in the 
plasma membrane that alters their function and their 
regulation by secondary messenger systems. 
N 
'EUROTRANSMITTER receptors  in  the  postsynaptic 
membrane  mediate  synaptic  transmission  at  all 
chemical synapses. Because of this central role, the 
receptors represent a likely site at which regulatory mecha- 
nisms might act to modulate synaptic transmission. Recent 
studies with nicotinic acetylcholine receptors (AChRs) t on 
chick ciliary ganglion neurons have indicated that a cAMP- 
dependent  mechanism  enhances  the  acetylcholine (ACh) 
sensitivity of the cells (Margiotta et al.,  1987a).  The en- 
hancement appears to represent an increase in the number 
of functional AChRs on the neurons since no changes that 
could account for the effect are observed in AChR single 
channel proPerties. The increased ACh sensitivity, however, 
occurs in the absence of protein synthesis, implying that it 
represents a conversion of preexisting nonfunctional AChRs 
to functional ones (Margiotta et al.,  1987a).  The source of 
the nonfunctional AChRs has not been determined. It could 
derive either from a substantial population of nonfunctional 
AChP,  s thought to be present in the plasma membrane (Mar- 
giotta et al., 1987b) or from a large population of intracellu- 
1. Abbreviations used in this paper: ACh, acetylcholine;  AChR, nicotinic 
acetylcholine  receptor;  ~t-Bgt, a-bungarotoxin;  BrACh, bromoacetylcho- 
line; DTNB, 5,5-dithio-bis(2-nitrobenzoate);  8-Br-cAMP, 8-bromoadeno- 
sine 3',5'-cyclicmonophosphate; 3H-NE, 3H-norepinephrine; IBMX, 3-iso- 
butyl-l-methylxanthine;  n-Bgt, neuronal bungarotoxin. 
lar AChRs known to be contained in the neurons (Stollberg 
and Berg,  1987). 
The possibility that the number of functional AChRs on 
cells can be increased by a cAMP-dependent process sug- 
gests ways in which cell-cell interactions might regulate syn- 
aptic signaling. Regulation of this type apparently does not 
apply to AChRs in vertebrate skeletal muscle or electric or- 
gan.  Activation of cAMP-dependent processes  in  muscle 
reduces  ACh  sensitivity in  a  manner consistent with the 
receptors  becoming  more  susceptible  to  agonist-induced 
densensitization (Albuquerque  et al.,  1986;  Middleton et 
al., 1986). Reconstitution experiments have directly demon- 
strated that cAMP-dependent phosphorylation of electric or- 
gan AChRs enhances agonist-induced desensitization of the 
receptors (Huganir et al., 1986). Neuronal AChRs, however, 
are known to differ from muscle AChRs in certain pharmaco- 
logical,  structural,  and regulatory aspects (Boulter et al., 
1986,  1987; Jacob and Berg, 1987, 1988; Patrick and Stall- 
cup,  1977a,  b;  Whiting and Lindstrom,  1986, 1987).  The 
ability to  recruit functional AChRs from a  nonfunctional 
receptor pool by a cAMP-dependent process could provide 
neurons a useful flexibility in detecting synaptic signals that 
would be unnecessary at the neuromuscular junction. 
AChRs on bovine adrenal chromaffin cells appear to be of 
the neuronal type. They resemble neuronal AChRs in single 
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minants  (Fenwick et al.,  1982a;  Higgins and Berg,  1987, 
1988a, b). This is expected since adrenal chromaffin cells 
derive from the neural crest and share many properties with 
sympathetic neurons. As a result, an examination of  the adre- 
nal chromaffin AChR is likely to provide information about 
receptor regulation that is applicable to neurons as well as 
endocrine cells.  Here we report that cAMP analogues en- 
hance the AChR response of  bovine adrenal chromaffin cells, 
and, as in the case of chick ciliary ganglion neurons, do so 
without detectably increasing the total number of AChRs on 
the cell surface. The enhanced response involves an activa- 
tion or conversion of preexisting AChRs on the cell surface, 
and cannot be explained either by synthesis of new receptors 
or by the selective transport of functional receptors to the 
plasma membrane from an intracellular pool. Unexpectedly, 
the  nicotinic  response of AChRs  newly  inserted  into the 
plasma membrane cannot be enhanced by cAMP analogues; 
only  older  AChRs  are  responsive  to  the  treatment.  The 
findings complement observations described in the preced- 
ing paper  suggesting  that  AChRs  newly  inserted  into  the 
plasma membrane are more efficacious than older receptors 
(Higgins and Berg,  1988b). 
Results 
All other procedures, including preparation of cultures, determination of 
~25I-mAb 35 binding, measurement of 3H-norepinephrine (3H-NE) release, 
and affinity alkylation of AChRs were carried out as described in the accom- 
panying paper (Higgins and Berg,  1988b). 
Materials 
8-bromoadenosine 3',5'-cyclicmonophosphate (8-Br-cAMP), 8-bromogua- 
nosine  3',5'-cyclicmonophosphate,  dibutyryladenosine  3',5'-cyclicmono- 
phosphate, dibutyrylguanosine 3',5'-cyclicmonophosphate  and 3-isobutyl-1- 
methylxanthine (IBMX) were obtained from Sigma Chemical Co. (St. Louis, 
MO). All other materials were obtained from the sources indicated in the 
accompanying paper (Higgins and Berg,  1988b). 
Materials and Methods 
Enhancement of  AChR Function by cAMP  Analogues 
Possible regulation of bovine adrenal chromaffin AChRs by 
cAMP was examined first by incubating adrenal chromaffin 
cells  in  culture  with  membrane  permeant  analogues  of 
cAMP and measuring nicotine-induced 3H-NE release from 
the cells as an assay for AChR function. Nicotine was used 
160 
Electrophysiology 
The ACh sensitivity of bovine adrenal chromaffin cells in culture was deter- 
mined using intracellular recording techniques as previously described for 
neurotransmitter sensitivities of chick ciliary ganglion neurons (McEachern 
etal., 1985; Smith et al., 1983).  In brief, cultures were maintained at 37°C 
on the stage of a Leitz inverted microscope with phase contrast optics and 
were continuously perfused with recording medium composed of 137 mM 
NaCl,  5.4  mM  KCI,  0.81 mM  MgSO4,  0.92  mM  NazHPO4,  0.44  mM 
KH2PO4, 5.4  mM CaCI2,  5.6 mM glucose, and 2.5 mM Hepes, pH 7.4. 
Nicotine was routinely used as agonist rather than ACh so that muscarinic 
receptors would not be activated. Nicotine at 5 IxM was applied to individual 
cells by pressure (1-3  psi)  from a  pipette with a 4-6-1xm  tip positioned 
15-30 lam from the cell. Sensitivities measured in this way are likely to rep- 
resent "summed" responses of most of the functional receptors on the cell 
since experiments with dye-filled pipettes indicate that the procedure com- 
pletely immerses the soma in the ejected solution (Choi and Fischbach, 
1981; Smith et al.,  1983).  Chromatfin cells selected for measurement usu- 
ally had diameters of 25-40 ~tm and appeared well-attached to, but not flat- 
tened against, the substratum. Recordings were made using single intracel- 
lular electrodes with resistances of 60-120 megohms in conjunction with 
an amplifier and Wheatstone bridge circuit (model MT01; WPI, Inc., New 
Haven, CT). Current was injected into a cell to produce a holding potential 
of -50 mV, unless the resting potential was even more negative. This elimi- 
nated contributions from voltage-dependent ionic conductances since the 
current-voltage relationship was linear up to values of •-20  mV for the 
membrane potential, in agreement with previous reports (Fenwick et al., 
1982b).  Membrane depolarizations in response to nicotine were more nega- 
tive than -20 mV, and the current-voltage relationship was not changed by 
8-Br-cAMP treatment over the range of membrane potentials in which nico- 
tinic responses were recorded. Constant current pulses of 0.08-0.15 nA am- 
plitude and 50 ms duration were delivered. The nicotine-induced  membrane 
conductance (g,~) was calculated as the difference between the maximum 
input conductance in the presence of nicotine and the resting input conduc- 
tance immediately before application of the drug. Bath application of d-tu- 
bocurarine at  10 laM completely blocked gn~ in 15 out of 15 cells tested, 
confirming that the response was nicotinic as well as demonstrating the 
pressure injection used to apply nicotine did not by itself elicit a response. 
Data were accepted if the cell maintained a resting potential more negative 
than -35 mV in the absence of a holding potential, and the recording elec- 
trode was no more than 3 mV out of balance after withdrawal from the cell. 
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Figure  1.  Time  course  and  reversibility  of cAMP-dependent en- 
hancement of nicotine-induced 3H-NE release.  (A) Adrenal chro- 
malfin cultures were incubated with 0.5 mM 8-Br-cAMP for the in- 
dicated times before being rinsed and tested for nicotine-induced 
3H-NE  release.  (B)  Cultures  were incubated with 0.5  mM  8-Br- 
cAMP for  12-18 h,  rinsed,  incubated in culture medium without 
the cyclic nucleotide for the  indicated times,  and then tested for 
nicotine-induced 3H-NE release. Data are expressed as the percent 
net increase of release over values obtained for untreated cultures 
and  represent the mean  _+  SEM of three experiments, each per- 
formed with triplicate sets of cultures.  Lines were fit by eye in A 
and by linear regression analysis in B. 
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Percent net increase 
Nicotine-induced  K+-induced  *-~51-mAb 35 
Treatment  ~H-NE release  'H-NE release  binding sites 
8 Br-cAMP  66  +  12" (14)  -9  +  3 (5)  0  _+ 2 (4) 
dibutyryladenosine Y,5'-cyclicmonophosphate  51  ±  7* (6)  4  +  8 (5)  0  +  12 (4) 
8-bromoguanosine 3',5'-cyclicmonophosphate  -9  +  2 (5)  -10 +  5 (5)  4  +  11  (4) 
dibutyrylguanosine 3',5'-cyclicmonophosphate  -4  ±  6 (5)  1 +  7 (5)  6  +  8 (4) 
IBMX  36  +  3* (4)  1 +  7 (5)  -2  +  2 (3) 
IBMX  +  8-Br-cAMP  75  ±  7* (5)  -2  +  3 (5)  1 +  3 (4) 
adenosine  -20 ±  9 (6)  ND  17  +  2 (4) 
2-Cl-adenosine  -3  ±  13 (5)  ND  0  +  3 (3) 
AMP  -I  ±  2 (5)  ND  -5  ±  4 (4) 
Cultures were incubated  with the indicated  compound(s)  at 0.5 mM for 24 h (except IBMX which was supplied at I mM), rinsed, and then tested for 3H-NE 
release induced  by either 1 laM nicotine  or 54 mM K  +, or tested for t2~l-mAb  35 binding.  Basal release obtained in the absence  of secretogogue was subtracted 
in the ~H-NE release assays. Data are expressed as the percent net increase  over levels  obtained in untreated sister cultures and represent the mean + SEM for 
the number  of experiments indicated in parenthesis, with each experiment employing  triplicate sets of cultures. In control cultures nicotine-induced  3H-NE 
release was 5.9 +  1.0% (14) of the total ~H-NE present in the cells at the beginning  of the 3-min  test period, while K+-induced  ~H-NE release was 5.8 + 0.8% 
(5) of the total in the cells. 
* Significantly  different from untreated sister cultures, p < .005. 
routinely as the AChR agonist rather than ACh so that mus- 
carinic receptors  would not be activated.  Exposure of the 
cultures to 0.5 mM 8-Br-cAMP at 37°C produced a substan- 
tial increase in the amount of nicotine-induced 3H-NE re- 
lease. A maximum was obtained within 80 min and ranged 
between 30 and 120% net enhancement among experiments 
(Fig. 1 A). Because of the variation, results were always com- 
pared to controls run in the same experiment, and the ratios 
averaged among experiments. The enhancement was slowly 
reversible, having a half-time for decline of ~10 h after the 
8-Br-cAMP was  removed  from  the  extracellular  medium 
(Fig.  1 B).  A  second cAMP analogue as well as the mem- 
brane permeant phosphodiesterase  inhibitor IBMX  had  a 
similar effect on the cells (Table I). Combining IBMX and 
8-Br-cAMP  did  not  significantly increase  the  amount of 
nicotine-induced 3H-NE release over that caused by 8-Br- 
cAMP alone (Table I). The effect appeared to be specific for 
cAMP since it could not be mimicked by cGMP analogues 
or by noncyclic  adenine compounds. None of the compounds 
tested had any effect on the amount of 3H-NE released in re- 
sponse to  depolarization of the  cells by  54  mM  K +.  The 
results are consistent with a  cAMP-dependent process en- 
hancing the nicotinic response of the ceils. 
The possibility that cAMP analogues caused an increase 
in the number of AChRs on the cells was tested by measuring 
the number of ~25I-mAb 35 binding sites, mAb 35 has been 
shown  to  cross  react  with  the  bovine adrenal  chromaffin 
AChR (Higgins and Berg,  1987). No difference in the num- 
ber of antibody binding sites was detected on the surface of 
the cells after treatment with any of the compounds (Table I). 
To  confirm  that  the  cAMP  analogues  increased  AChR 
function as suggested by the 3H-NE release assay,  intracel- 
lular recording was  used to examine the  sensitivity of the 
cells to nicotine. Untreated control cells displayed a  mean 
gmc of 37  +  6 nS (n =  32) in response to a standard test ap- 
plication of 5 ~tM nicotine. Ceils that had first been incubated 
in 0.5 mM 8-Br-cAMP for  12-18 h displayed a mean g,~ of 
98  __+  11  nS (n  =  39).  Examples are shown in Fig. 2.  This 
constitutes a  net increase of 165  +  35%  and confirms the 
results of the release assay showing that cAMP analogues do 
enhance the nicotinic response of bovine adrenal chromaffin 
cells. 
The recordings were made in a  linear range of the cur- 
rent-voltage relationship for the cells, and 8-Br-cAMP treat- 
ment did not change the current-voltage relationship in the 
range examined (data not shown). Accordingly, the increased 
g,~c caused by  the  cAMP analogue did not include an in- 
creased contribution from voltage-dependent ion channels. 
The  observation that  a  larger  increase is  obtained in g,ac 
than  in nicotine-induced 3H-NE  release after  8-Br-cAMP 
treatment is  likely to be due to  NE release depending on 
Ca  ++ entry which is more proportional to changes in mem- 
brane voltage than to changes in g,~.  The membrane depo- 
larization caused by nicotine increased an average of 56  + 
12 % (n =  39) after 8-Br-cAMP treatment, which is in good 
agreement with the mean increase of 66 +  12% (n =  14 ex- 
periments)  in  nicotine-induced 3H-NE  release  caused  by 
8-Br-cAMP. 
Mechanism of the cAMP-dependent Enhancement 
The increased nicotinic response caused by cAMP analogues 
A  Figure  2.  cAMP-dependent 
enhancement of g.~c. Adrenal 
chromaflin cultures were  in- 
cubated  with and without 0.5 
mM 8-Br-cAMP for 12-18 h, 
rinsed, and analyzed with in- 
B  tracellular recording  for con- 
~~nanv~  ductance changes  in response 
to application  of 5 p.M nico- 
tine.  The traces  show mem- 
brane voltage;  downward de- 
flections  result  from constant 
current pulses passed through 
the recording electrode. The duration of nicotine  application is indi- 
cated by the horizontal bars. (A) Control; g,~¢ =  30 nS. (B) 8-Br- 
cAMP; g,~,. =  85 nS. Vertical bar,  10 mV; horizontal  bar, 0.5 s. 
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Figure 3. Effects of 8-Br-cAMP on the time course and concentra- 
tion  dependence  of  nicotine-induced  3H-NE release.  Cultures 
were incubated with (solid circles) or without (open circles) 0.5 
mM 8-Br-cAMP for 12-18 h and then tested for nicotine-induced 
3H-NE release by varying either the concentration of nicotine (A) 
or the time of exposure to it (B) in the standard assay. Data repre- 
sent the mean -I- SEM of four experiments in each case, with each 
experiment involving a triplicate  set of cultures. 
does not appear to represent a major change either in recep- 
tor affinity for agonist or in the kinetics of the secretory re- 
sponse. Both the dependence on agonist concentration and 
the time course of nicotine-induced 3H-NE release from the 
cells were the same after incubation with 8-Br-cAMP (Fig. 
3). Only the magnitude of the release was increased by the 
cyclic nucleotide. 
The ~25I-mAb 35 binding studies presented above (Table 
I) suggested that cAMP analogues did not increase the num- 
ber of AChRs on the cells,  and therefore implied that the 
enhanced  nicotinic  response  must  represent  an  increased 
efficacy of existing AChRs. This was corroborated by show- 
ing that inhibiting synthesis of new receptors using a concen- 
tration of puromycin that blocked >98 % of protein synthesis 
did not diminish the ability of 8-Br-cAMP to increase the 
nicotinic  response  (data  not  shown).  Accordingly,  the  in- 
crease must represent  a  change  in  activity of the  existing 
AChR population. 
A possible mechanism for the enhanced nicotinic response 
is provided by the precedent of cAMP-dependent regulation 
of AChRs on chick ciliary ganglion neurons. Recent studies 
suggest that only a fraction of the AChRs on the neurons in 
culture  is functional,  and that a  cAMP-dependent process 
can  increase  the  fraction  of receptors  that  are  functional 
(Margiotta et al., 1987a, b). Bovine adrenal chromaffin cells 
may also have nonfunctional AChR in the plasma membrane. 
Fenwick  et al.  (1982a),  using  patch clamp analysis,  esti- 
mated  that  in  culture  the  cells  have  100-200  functional 
AChRs per cell.  The number of '25I-mAb 35 binding sites 
under  similar  culture  conditions  is  °,,1.6  ×  104  per  celt 
(Higgins and Berg,  1987). Assuming two mAb 35 sites per 
AChR results in over an order of magnitude discrepancy be- 
tween the number of AChRs determined with antibody bind- 
ing and the number determined physiologically. The putative 
nonfunctional AChRs on the cell surface would contribute a 
source of receptors that may be converted into a functional 
form by a cAMP-dependent process. An alternative possibil- 
ity is that the cAMP-dependent process induces the transfer 
of preexisting intracellular AChRs to the plasma membrane. 
About 20% of the total AChRs associated with bovine adre- 
nal chromaffin cells in culture constitute an intracellular pool 
of receptor  of unknown  significance  (Higgins  and  Berg, 
1988a).  If only 5-10%  of the surface AChRs are normally 
functional,  and a  cAMP-dependent process  selectively re- 
cruited functional AChRs from the intracellular pool, a two- 
to  threefold  increase  in  nicotinic  response  might  occur 
without a detectable change in the number of antibody bind- 
ing sites on the cell surface. 
Two types of experiments eliminated the possibility that 
the cAMP-dependent enhancement of the nicotinic response 
is mediated predominantly by recruitment of preexisting in- 
tracellular AChRs. Both types of experiments employed the 
strategy of first selectively blocking AChRs on the cell sur- 
face and then determining whether cAMP analogues could 
still induce a nicotinic response. If so, the implication would 
have been that the cyclic nucleotides recruited AChRs from 
intracellular pools that had not been inactivated by the treat- 
ment with receptor blockers. In the first procedure neuronal 
bungarotoxin (n-Bgt) was used to block AChRs on the cells 
(Higgins  and  Berg,  1987).  After  washing  away  unbound 
n-Bgt and incubating with 8-Br-cAMP, the cells were tested 
for nicotine-induced  3H-NE release. It was not practical to 
use high enough concentrations of n-Bgt to achieve complete 
block of all previously existing AChRs on the cell surface. 
Nonetheless, the 8-Br-cAMP treatment increased the amount 
of agonist-induced release only as much as expected for an 
effect on the residual surface AChRs remaining unoccupied 
by n-Bgt;  i.e.,  the amount of nicotine-induced  3H-NE re- 
Table II. Effects of  AChR Blockade on Regulation of 
Nicotinic Response by cAMP Analogues 
Nicotine-induced 3H-NE 
release (%  of untreated 
cultures)  8-Br-cAMP- 
dependent net 
without  with  enhancement 
Treatment  8-Br-cAMP  8-Br-cAMP  in percent  n 
None  100  149  +- 9*  49 +  9  (3) 
n-Bgt  39 +- 1  62  +  5*  59  +  13  (3) 
a-Bgt  107  +  6  143  +_ 6*  35  5:8  (3) 
DTT, DTNB  105 +_ 5  163  +, 9*  55  5:10  (7) 
DTT, BrACh, DTNB  12 +, 2  16 _+ 3  ND  (3) 
BrACh  98 +_ 9  ND  ND  (3) 
Cultures received the indicated treatments and then were rinsed, incubated with 
or without 0.5 mM 8-Br-cAMP for 2 h, and assayed for nicotine-induced 3H-NE 
release. Data on release are presented as a percent of the values obtained from 
untreated sister cultures, and represent the mean  _+ SEM for the number of ex- 
periments indicated in parenthesis, with each experiment being done with a 
triplicate set of cultures. None,  no treatment; n-Bgt,  1 l,  tM  n-Bgt  1 h  before 
8-Br-cAMP treatment; ct-Bgt, 1 I.tM a-Bgt  1 h  before and 2  h  during 8-Br- 
cAMP treatment; DTT, DTNB, affinity alkylation protocol in which incubation 
with BrACh was omitted; DIRT. BrACh, DTNB,  affinity alkylation protocol; 
BrACh,  affinity alkylation protocol with the DTT and DTNB  steps omitted. 
* Significantly different from paired condition without 8-Br-cAMP,  p  <  .005. 
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by 8-Br-cAMP as was the release in unblocked control cul- 
tures  (Table II). If the  8-Br-cAMP effect depended on re- 
cruitment of intracellular AChRs,  the absolute increase in 
nicotine-induced 3H-NE release brought on by 8-Br-cAMP 
should not have been diminished by n-Bgt and would have 
contributed  to  the  secretory  response  in  addition  to  that 
resulting  from  residual  unblocked  AChRs.  The  increase 
would have represented more than a doubling of the residual 
release observed in the n-Bgt-treated cultures in the absence 
of 8-Br-cAMP. This was not the case. 
In the second procedure, blockade of surface AChRs was 
achieved  by  affinity  alkylation  with  bromoacetylcholine 
(BrACh) as previously described for AChRs from electric or- 
gan (Damle et al.,  1978)  and PC12 cells (Leprince,  1983). 
Cells  were  incubated  with  dithiothreitol  (DTT)  to  reduce 
suifhydryls on the cell surface, reacted with BrACh to affinity 
alkylate AChRs, and reoxidized with DTNB to restore func- 
tion  to  nonalkylated  AChRs.  The  procedure  specifically 
blocked the nicotinic response.  No loss of K+-induced 3H- 
NE  release  was  observed,  and  little  if any decrement  in 
nicotine-induced 3H-NE release occurred if either the BrACh 
step or the DTT and DTNB steps were omitted from the pro- 
tocol. After blockade of surface AChRs by affinity alkylation 
with BrACh, no increase in the nicotinic response could sub- 
sequently be induced by 8-Br-cAMP (Table II). The small 
amount of nicotine-induced release observed in the experi- 
ment arose from new AChRs appearing because of the nor- 
mal rate of insertion  for AChRs  in  the  plasma membrane 
during the 2-h period between alkylation and assay for nico- 
tine-induced  3H-NE  release  (Higgins  and  Berg,  1988b). 
Both the affinity alklyation experiments and the n-Bgt blockade 
experiments indicate that the increase in nicotinic response 
brought on by cAMP analogues is not due to recruitment of 
intracellular AChRs. This, together with the demonstration 
that the effect depends on preexisting AChRs,  supports the 
conclusion  that  the  cAMP-dependent  enhancement  of the 
nicotinic response involves an effect on existing AChRs in 
the surface membrane of the cells. This interpretation is in 
agreement with the observation that 8-Br-cAMP enhance- 
ment of the nicotinic response is not accompanied by a de- 
tectable increase in the number of ~25I-mAb 35 binding sites 
on the cells (Table I). 
Bovine adrenal chromaffin cells have ct-Bgt receptors that 
have nicotinic pharmacology, but are distinct from classical 
AChRs that mediate conductance of monovalent cations (Hig- 
gins and Berg, 1987,  1988a). The possibility that cholinergic 
activation of ct-Bgt receptors was involved in the cAMP-de- 
pendent effect on AChRs was tested by treating the cells with 
ct-Bgt before and during exposure to 8-Br-cAMP. No effect 
of ct-Bgt was observed on the enhancement of AChR function 
by the cyclic nucleotide (Table II). 
Differences in cAMP-dependent Regulation 
of New and Old AChRs 
The enhancement of the nicotinic response by cAMP ana- 
logues described above represents an effect on a population 
of AChRs  with  a  steady-state  distribution  of ages  in  the 
plasma membrane. Results presented in the accompanying 
paper suggest that AChR  efficacy may vary with  receptor 
age (Higgins and Berg,  1988b).  Accordingly, new and old 
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Figure 4. cAMP-dependent enhancement of the nicotinic response 
from cells with AChRs of different ages. Cells having exclusively 
new AChRs were obtained either by using antigenic modulation to 
remove existing AChRs from the cell surface and then allowing the 
cells to recover for 6 h (solid bars) or by using affinity alkylation 
with BrACh to block the function of existing AChRs on the cells 
and then letting them recover for 4 h (open bar). Cells having exclu- 
sively old AChRs were obtained by maintaining cells for 27 h in 
tunicamycin to prevent appearance of new receptors in the plasma 
membrane (stippled bars). To produce a population of new AChRs 
that aged in synchrony, cells were allowed to recover from antigenic 
modulation for 3-4 h and then were maintained in tunicamycin for 
24  h  before  assay  (flecked bar). Details  of the  procedures  are 
provided in the text. The effect of 0.5 mM 8-Br-cAMP for 2 h on 
either  the nicotine-induced  3H-NE release (A) or on the g,~¢ (B) 
was then determined. Data are expressed as the percent increase in 
the AChR response caused by 8-Br-cAMP and represent the mean 
+  SEM of four experiments performed with triplicate sets of cul- 
tures in A and the mean _+ SEM for 24-39 cells for each of the con- 
ditions shown in B. 
AChRs  were examined  separately  for regulation  by  8-Br- 
cAMP. New AChRs were obtained in isolation by using anti- 
genic modulation with mAb 35 to clear existing AChRs from 
the cell surface (Higgins and Berg,  1988b).  A 6-h recovery 
period then allowed newly synthesized AChRs to accumulate 
in the plasma membrane. 8-Br-cAMP had no effect on the 
nicotinic response of new receptors (Fig. 4 A). In a second 
strategy to examine the functional properties of new AChRs, 
affinity alkylation was used to block completely activation of 
existing AChRs on the cells.  After a 4-h recovery period to 
permit the accumulation of new AChRs on the cells,  mea- 
surements of nicotine-induced 3H-NE release again demon- 
strated that 8-Br-cAMP was unable to enhance the response 
of new AChRs (Fig. 4 A). In contrast, shifting the mean age 
of the AChR population to higher values revealed a marked 
enhancement of receptor function by 8-Br-cAMP. This was 
demonstrated by incubating cultures in tunicamycin for 27 h 
to block appearance of new AChRs, thereby increasing the 
average age of the remaining AChRs. Cultures treated in this 
manner displayed an even greater enhancement of nicotine- 
induced 3H-NE release by 8-Br-cAMP than did control cul- 
tures (Fig. 4  A).  Neither antigenic modulation nor 27 h  in 
tunicamycin altered the amount of 3H-NE release induced 
by 54 mM K ÷, indicating that the effects observed on nico- 
tine-induced  release were specific. 
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Figure 5. Acquisition of AChR sensitivity to cAMP-dependent regu- 
lation. AChRs on the surface of adrenal chromaffin cells in culture 
were removed by exposing the cultures to mAb 35.  The cultures 
were then allowed to recover for the indicated times before assaying 
for  nicotine-induced  3H-NE release  with  and  without  0.5  mM 
8-Br-cAMP treatment.  Cultures receiving 8-Br-cAMP were incu- 
bated in the compound starting 4 h before measurement of 3H-NE 
release. Data are expressed as the percent enhancement of nicotine- 
induced  JH-NE release  produced  by 8-Br-cAMP, and  represent 
the mean +  SEM of four experiments done with triplicate sets of 
cultures. 
To  show  directly  that  AChRs  progress  from  an  8-Br- 
cAMP-insensitive stage to a sensitive one, experiments were 
designed to follow the fate of new AChRs. Cells were treated 
with mAb 35 to remove surface AChRs and then incubated 
for 3-4 h to allow new AChRs to accumulate in the plasma 
membrane.  Tunicamycin  was  then  added  to  the  culture 
medium to prevent additional AChRs from appearing while 
the existing "new" receptors aged.  After a  24-h period  in 
tunicamycin the cells were tested for nicotine-induced  3H- 
NE release, with and without a 2-h exposure to 0.5 mM 8-Br- 
cAMP.  The  cyclic  nucleotide  caused  a  doubling  of  the 
nicotine-induced  release,  showing  that  AChRs,  which  are 
initially  insensitive  to  modulation  by the  cyclic  AMP-de- 
pendent process, later became sensitive to it (Fig. 4 A). 
Intracellular recording confirmed the results of the release 
assay, showing differences in the response of new and old 
AChRs to 8-Br-cAMP treatment. New AChRs were opera- 
tionaUy defined in this case as those having accumulated on 
the cells within 6-8 h after antigenic modulation by mAb 35 
to remove preexisting AChRs.  Old AChRs were taken to be 
those present 22-26 h  after treatment of the cultures with 
tunicamycin to prevent the appearance of new AChRs. 8-Br- 
cAMP treatment had no effect on the nicotinic sensitivity of 
cells with new AChRs (Fig.  4 B).  The compound did en- 
hance the nicotinic response of cells containing old AChRs, 
and the enhancement was significantly greater (p <  0.005) 
than that caused by 8-Br-eAMP on untreated control neurons 
having a  steady-state distribution  of receptor ages. 
The rate at which AChRs acquire the ability to be modu- 
lated by a cAMP-dependent process was examined by remov- 
ing  surface  AChRs  through  antigenic  modulation,  allow- 
ing the cells to accumulate new AChRs, and then determining 
the effect of 8-Br-cAMP on nicotine-induced 3H-NE release 
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Figure 6. Recovery of AChR sensitivity to cAMP-dependent regula- 
tion  after partial  antigenic  modulation  of the  receptors.  Partial 
removal of AChRs from adrenal  chromaflin ceils  in culture  was 
achieved by exposing the cells to a low concentration of mAb 35. 
The cultures were then allowed to recover for the indicated times 
and  assayed  for nicotine-induced  3H-NE release.  Solid  circles, 
8-Br-cAMP applied at 0.5 mM 4 h before conducting the release 
assay; open squares,  ceils receiving no cyclic nucleotide. Similar 
results were obtained in two other experiments. 
from the cells at subsequent times. The results demonstrate 
that within 20 h the cells reach steady-state, having a nicotinic 
response that is enhanced by 8-Br-cAMP to the same extent 
as cells with AChRs before antigenic modulation (Fig.  5). 
The possibility that the time dependence reflected recovery 
of the cAMP-dependent process itself after antigenic modu- 
lation rather than events at the level of AChRs was addressed 
in the following manner. A partial removal of surface AChRs 
was achieved by incubating cells with low concentrations of 
mAb 35.  The cells were then exposed to 8-Br-cAMP and 
tested  for  nicotine-induced  3H-NE  release.  The  propor- 
tional enhancement caused by the cyclic nucleotide (60%) 
was identical to that observed with unmodulated sister cul- 
tures, indicating that the relevant cAMP-dependent mecha- 
nism had not been compromised by the antigenic modulation 
used to clear AChRs from the cell surface (Fig. 6).  The re- 
suits indicate that a time-dependent maturation of the AChR 
and/or an associated component confers on the receptor a 
sensitivity to modulation by a cAMP-dependent process. 
Discussion 
The results presented here show that a cAMP-dependent pro- 
cess  increases  the  nicotinic  response  of  bovine  adrenal 
chromaffin AChRs, and that it does so by increasing the func- 
tion of AChRs already present in the plasma membrane. The 
cAMP-dependent regulation provides, in principle, a mecha- 
nism by which cell-cell interactions  influencing  adenylate 
cyclase activity could modulate the detection of cholinergic 
signals by neurons and endocrine cells.  Unexpectedly, the 
effectiveness of the  cAMP-dependent  process  depends  on 
AChR age. AChRs newly inserted into the plasma membrane 
are not enhanced in function by the process, but later do be- 
come responsive to cAMP-dependent modulation. 
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of AChR function is indicated by the fact that cAMP ana- 
logues as well as a phosphodiesterase inhibitor cause an in- 
creased nicotinic response from the cells while cGMP ana- 
logues  and  noncyclic adenine  compounds have no  effect. 
That the process is AChR-dependent is demonstrated by the 
finding that nicotine-induced 3H-NE release is enhanced by 
cAMP analogues while K+-induced 3H-NE release is  not. 
Intracellular  recording  confirms the  increased  AChR-me- 
diated response,  showing a  substantial  increase in gnic for 
cells incubated with 8-Br-cAME The extent of the increase, 
165 %, is significantly greater than the mean increase of 66 % 
observed for nicotine-induced 3H-NE release.  The differ- 
ence  in  results  presumably  arises  from the  fact that  gn~c 
reflects a  change in membrane conductance while 3H-NE 
release depends on Ca  ++ entry and therefore on changes in 
membrane  potential  needed  to  activate voltage-dependent 
calcium channels.  Membrane conductance and membrane 
potential would not be expected to increase in parallel since 
the driving force on ions changes as a function of voltage. 
Indeed, the 56 % net enhancement of the nicotine-induced 
membrane depolarization after 8-Br-cAMP treatment agrees 
well  with  the  66%  net  enhancement of the  secretory re- 
sponse.  Measurement  of membrane  conductance  change 
provides a more accurate assessment of relative AChR acti- 
vation than does the release assay. Nevertheless, results from 
the two kinds of assays are in good qualitative agreement un- 
der the conditions used,  and lead to the same conclusions 
about AChR regulation by cAMP. 
Conflicting accounts have appeared describing the effects 
of cAMP analogues on bovine adrenal chromaffin AChRs 
(Adams  and  Boarder,  1987;  Cheek  and  Burgoyne,  1987; 
Marriott et al.,  1988;  Morita et al.,  1987a,  b).  Generally, 
agents thought to increase or substitute for cAMP have been 
reported either to increase nicotine- and K+-induced cate- 
cholamine release in parallel or to inhibit nicotine-induced 
release. We have no explanation for the discrepancies other 
than to point out that different conditions were used to pre- 
pare the cells, to activate cAMP-dependent processes, and to 
assay receptor-mediated catecholamine release. In the pres- 
ent  studies  intracellular  recording  unequivocally demon- 
strated that cAMP analogues did increase AChR function in 
bovine adrenal chromaffin cells under the conditions used. 
Several lines of evidence indicate that the enhanced nico- 
tinic response brought on by cAMP occurs by influencing 
AChRs  already present in the plasma  membrane.  The in- 
crease in nicotine-induced 3H-NE release caused by 8-Br- 
cAMP occurs relatively rapidly. The half-time for onset of 
the increase is "~30 min which presumably reflects the time 
requirement for adequate penetration of the plasma mem- 
brane by the cAMP analogue. The increase is not blocked 
by inhibiting protein synthesis and it is not accompanied by 
a detectable increase in the total number of AChRs on the 
surface of the cells. The latter finding suggests that AChRs 
are not drawn from the population of intracellular receptors 
to produce the increased response. This conclusion is also 
supported  by  the  observation that  functional  blockade  of 
AChRs in the plasma membrane before incubating the cells 
with 8-Br-cAMP prevents the cyclic nucleotide from enhanc- 
ing the secretory response. The methods of blockade, i.e., 
incubation  with  n-Bgt  or  affinity alkylation  with  BrACh, 
should not have affected intracellular AChRs which would 
have been inaccessible to the blocking reagents and therefore 
still available for transfer to the plasma membrane by 8-Br- 
cAME had this served as the mechanism. 
The mechanism of enhancement requires further study. 
Patch clamp analysis of AChRs  on chick ciliary ganglion 
neurons indicates that cAMP analogues increase the ACh re- 
sponse of the cells by converting nonfunctional AChRs to 
functional  receptors,  rather  than  by  changing  the  single 
channel properties of functional AChRs  (Margiotta et al., 
1987b). It is possible that a similar mechanism is involved 
here, since, as described earlier, the number of functional 
AChRs  reported on bovine adrenal chromaffin cells (Fen- 
wick et al.,  1982a) may be substantially smaller than the to- 
tal number of AChRs detectable in the plasma membrane 
(Higgins and Berg, 1987, 1988a). Data from the 3H-NE re- 
lease assay suggest that the enhanced response caused by 8- 
Br-cAMP does not involve a change in affinity of agonist for 
the bovine receptors or in the kinetics of the secretory re- 
sponse to AChR activation. Nonetheless, patch clamp analy- 
sis will be required to determine whether a change in single 
channel properties of the AChR population as a whole might 
account for the enhanced response. Increases in single chan- 
nel conductance, mean channel open time, or probability of 
channel  opening,  or  a  decrease  in  desensitization  could 
Cause the observed enhancement and would not be detected 
by the methods used here. Cholinergic action at ~t-Bgt recep- 
tors (Higgins and Berg, 1988a) does not appear to mediate 
the cAMP regulation of AChR function since chronic block- 
ade of the receptors with ct-Bgt did not prevent 8-Br-cAMP 
from enhancing nicotine-induced 3H-NE release. 
A  reasonable  hypothesis  for the  mechanism  by  which 
cAMP analogues enhance AChR function is that they acti- 
vate a cAMP-dependent protein kinase that phosphorylates 
either the AChR directly or a related component that acts in- 
directly to increase the nicotinic response, cAMP-dependent 
kinases alter the functional state of other types of ion chan- 
nels (Armstrong and Eckert, 1987; Brum et al., 1983; Ewald 
et al.,  1985; Flockerzi et al.,  1986; Shuster et al.,  1985). 
Direct phosphorylation of AChR from electric organ by a 
cAMP-dependent protein kinase increases agonist-induced 
desensitization of the  receptor (Huganir  et al.,  1986).  A 
similar regulation may apply to muscle AChRs (Albuquer- 
que et al.,  1986; Middleton et al.,  1986). AChRs on chick 
ciliary ganglion neurons display a small increase in agonist- 
induced desensitization after the cells are incubated with 
cAMP analogues,  but the effect is minor compared to the 
large increase in the ACh response resulting from the appar- 
ent increase in number of functional AChRs that the cAMP 
analogues cause (Margiotta et al.,  1987a).  Deduced amino 
acid sequences for muscle and neuronal AChR subunits sug- 
gest differences in the number and location of potential phos- 
phorylation sites for a cAMP-dependent protein kinase (Boul- 
ter et al.,  1986; Deneris et al.,  1988; Goldman et al.,  1987; 
Nefet al.,  1988; Wada et al.,  1988), and provide a possible 
molecular basis for the different regulatory effects of cAMP 
analogues  on  the  two  types  of AChRs  (Margiotta  et al., 
1987a). A difficulty with the notion that differences in phos- 
phorylation sites account for the different regulatory effects, 
however, comes from studies on the rat pheochromocytoma 
cell line PCI2.  PC12  cells have AChRs that appear to be 
similar to those of bovine adrenal chromaffin cells (Boulter 
et al., 1986, 1987) and chick ciliary ganglion neurons (Boyd 
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when challenged with a cAMP analogue or incubated with 
forskolin to elevate intracellular cAMP levels (Amy and Ben- 
nett, 1983; McHugh and McGee, Jr.,  1986). The results im- 
ply that either PC12 cell AChRs are refractory to the kind 
of phosphorylation proposed here or that regulation of neu- 
ronal AChR function by a cAMP-dependent process involves 
other events that do not normally occur in the PC12 cell line. 
The finding that new and old AChRs on bovine adrenal 
chromaffin cells differ in their regulation by cAMP suggests 
that the receptor and/or its associated components exist in 
different functional states in the membrane. Measurements 
of both  nicotine-induced  3H-NE  release  and  gn+~ indicate 
that cAMP analogues are unable to increase the agonist re- 
sponse of AChRs newly inserted in the plasma membrane. 
Two lines of evidence indicate that the refractoriness of new 
AChRs  in this respect is not a  limitation of the regulatory 
process per se. First, the same refractoriness to cAMP regu- 
lation was seen for new AChRs accumulating on cells after 
antigenic modulation and after affinity alkylation.  It is un- 
likely that both procedures selectively impaired the cAMP- 
dependent regulatory process in such a manner as to prevent 
it from acting on new AChRs.  Second,  when some AChRs 
were allowed to remain after antigenic modulation, the resid- 
ual  nicotinic  response could  still  be  enhanced by  cAMP- 
dependent regulation to the same proportional extent, dem- 
onstrating that the regulatory process itself withstood anti- 
genic modulation. 
The event that renders AChRs responsive to modulation by 
a cAMP-dependent process may also be the event that alters 
the functional state of the receptor as a consequence of age 
in  the plasma membrane.  The two changes do occur with 
similar time courses. One possibility is that the event initially 
involves a dephosphorylation of the receptor.  For example 
AChRs may arrive in the plasma membrane predominantly 
in a phosphorylated, active form, and then slowly become 
dephosphorylated, perhaps through the action of a membrane- 
associated phosphatase, to produce receptors that are less ac- 
tive.  Rephosphorylation by  a  cAMP-dependent  protein ki- 
nase might then convert the receptors back to the more active 
form. An alternative possibility is that AChRs appear in the 
membrane in an active form, ano then slowly become associ- 
ated  with another component that  restricts  their  function. 
The role of the cAMP-dependent process in this case might 
be  to release  AChRs  from association with the restrictive 
component. 
While the results are consistent with a single event being 
responsible for the changes,  they do not exclude a  host of 
other possibilities such as the existence of several competing 
control mechanisms whose balance or access changes with 
receptor age.  The primary  significance  of the results pre- 
sented  here  is  that  they  demonstrate  a  cAMP-dependent 
modulation of the nicotinic response and indicate a "matura- 
tion" of AChRs in the plasma membrane with respect to func- 
tion and regulation by secondary messenger systems. In view 
of the similarity between neuronal and adrenal chromaffin 
AChRs, it seems likely that similar conclusions may hold for 
at least some classes of neuronal receptors, implying that the 
regulatory mechanisms involved could influence the detection 
of synaptic input at neuronal as well as endocrine targets. 
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